Novartis AG buys Indiana biotech startup Endocyte for $2.1B – Idaho Statesman

Novartis AG buys Indiana biotech startup Endocyte for $2.1B
Idaho Statesman
Swiss drug giant Novartis AG has purchased a biotech startup co-founded by a Purdue University cancer researcher for $2.1 billion. Under the deal announced Thursday, Novartis agreed to purchase Endocyte Inc. for $24 per share. That’s 54 percent more …

and more

…read more

Source:: Startup Tech News From Google News

Leave a Comment